Waters Corporation
Waters Shareholders Approve Share Issuance for BD Biosciences Combination
Summary
On January 27, 2026, Waters Corporation shareholders approved the issuance of shares for the proposed combination with Becton, Dickinson and Company's Biosciences & Diagnostic Solutions business. The approval was achieved with approximately 99% of votes in favor, and the transaction is expected to close on February 9, 2026, subject to customary closing conditions. This approval marks a significant step towards the completion of the transaction, which will result in SpinCo becoming a wholly owned subsidiary of Waters.
Profitelligence Alerts
Get alerts for WAT
Be first to know when Waters Corporation files with the SEC.
Filing Categories
Advertisement
About Waters Corporation
Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.
Official SEC Documents
Advertisement